English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/27333
Compartir / Impacto:
Add this article to your Mendeley library MendeleyBASE
Citado 40 veces en Web of Knowledge®  |  Ver citas en Google académico
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL

A novel N-methyl-D-aspartate receptor open channel blocker with in vivo neuroprotectant activity

AutorPlanells-Cases, Rosa; Montoliu, Carmina; Humet, Marc; Fernández, Asia M.; García-Martínez, Carolina; Valera, Elvira; Merino, Jaime M.; Pérez-Payá, Enrique ; Messeguer Peypoch, Ángel; Ferrer-Montiel, Antonio
Fecha de publicación1-jul-2002
EditorAmerican Society for Pharmacology and Experimental Therapeutics
CitaciónJournal of Pharmacology and Experimental Therapeutics 302(1): 163-173 (2002)
ResumenExcitotoxicity has been implicated in the etiology of ischemic stroke, chronic neurodegenerative disorders, and very recently, in glioma growth. Thus, the development of novel neuroprotectant molecules that reduce excitotoxic brain damage is vigorously pursued. We have used an ionic current block-based cellular assay to screen a synthetic combinatorial library of trimers of N-alkylglycines on the N-methyl-D-aspartate (NMDA) receptor, a well known molecular target involved in excitotoxicity. We report the identification of a family of N-alkylglycines that selectively blocked the NMDA receptor. Notably, compound 3,3-diphenylpropyl-N-glycinamide (referred to as N20C) inhibited NMDA receptor channel activity with micromolar affinity, fast on-off blockade kinetics, and strong voltage dependence. Molecule N20C did not act as a competitive glutamate or glycine antagonist. In contrast, saturation of the blocker binding site with N20C prevented dizolcipine (MK-801) blockade of the NMDA receptor, implying that both drugs bind to the same receptor site. The N-alkylglycine efficiently prevented in vitro excitotoxic neurodegeneration of cerebellar and hippocampal neurons in culture. Attenuation of neuronal glutamate/NMDA-induced Ca(2+) overload and subsequent modulation of the glutamate-nitric oxide-cGMP pathway seems to underlie N20C neuroprotection. Noteworthy, this molecule exhibited significant in vivo neuroprotectant activity against an acute, severe, excitotoxic insult. Taken together, these findings indicate that N-alkylglycine N20C is a novel, low molecular weight, moderate-affinity NMDA receptor open channel blocker with in vitro and in vivo neuroprotective activity, which, in due turn, may become a tolerated drug for the treatment of neurodegenerative diseases and cancer.
Descripción11 pages, 9 figures, 1 table.-- PMID: 12065713 [PubMed].
Versión del editorhttp://dx.doi.org/10.1124/jpet.302.1.163
ISSN0022-3565 (Print)
1521-0103 (Online)
Aparece en las colecciones: (IQAC) Artículos
Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Mostrar el registro completo

NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.